doctor and patient: when optimism is unrealistic
patients think experimental cancer drugs will work for them, even though fewer than 5 percent ever benefit from early-phase studies.
http://feeds.nytimes.com/click.phdo?i=fa7abb0c10ec471dcc23c58e22b18ce6
32381
05 Mar 2011 07:10:06
nyt
health